Organization
Froedtert and the Medical College of Wisconsin Workforce Health, Milwaukee, WI
3 abstracts
Abstract
DUET-01: A first-in-human, phase 1/2 study of BOXR1030 in patients with advanced glypican-3-positive solid tumors.Org: Froedtert and the Medical College of Wisconsin Workforce Health, Milwaukee, WI, SOTIO Biotech Inc., Boston, MA, SOTIO Biotech a.s., Prague, Czech Republic, SOTIO Biotech AG, Basel, Switzerland, Texas Oncology–Baylor Charles A. Sammons Cancer Center, Dallas, TX,
Abstract
Impact of cytoreductive nephrectomy (CN) and treatment (trt) sequence on overall survival (OS) in metastatic non-clear cell renal cell cancer (nccRCC).Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, The Medical College of Wisconsin, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Froedtert and the Medical College of Wisconsin Workforce Health, Milwaukee, WI,
Abstract
Correlation of cardiovascular disease with racial disparities in endometrial cancer outcomes.Org: Medical College of Wisconsin, Froedtert and the Medical College of Wisconsin Workforce Health, Milwaukee, WI,